论文部分内容阅读
吉林柳河博士乐制药有限公司生产的“孚舒达”是93年经卫生部批准的西药三类新药(批号为93X—130号),经过近五年的临床应用疗效显著,在治疗多种妇科疾病获重大突破,尤其是突破了老年性阴道炎、细菌性阴道病无特效安全用药的现状。经中华医学会重点推广工程项目评审专家组论证和专家认证委员会复审认证,认为该药在治疗妇科阴道炎疾病上获重大突破,在临床有较大的推广价值,同意将“孚舒达”阴道栓列入中华医学会重点推广工程项目,向国内推荐、推广。
The “Fu Shuda” produced by Dr. Liu He Pharmaceutical Co., Ltd. in Jilin Province is the third-category western medicine approved by the Ministry of Health in 1993 (Lot No. 93X-130). After nearly five years of clinical application, the effect is remarkable. Major breakthroughs in disease, especially the breakthrough of senile vaginitis, bacterial vaginosis no special effects of safe medication status. The Chinese Medical Association focus on promoting the project evaluation panel validation and expert certification committee review and certification that the drug in the treatment of gynecological vaginitis disease has been a major breakthrough in the clinical have greater promotional value, agreed to the “Vousoucha” vagina Tied included in the Chinese Medical Association to promote key projects, to the domestic recommendation, promotion.